A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms

• Published in: Chemico-biological interactions Vol. 393; p. 110940
• Main Authors: Asghar, Andleeb, Chohan, Tahir Ali, Khurshid, Umair, Saleem, Hammad, Mustafa, Mian Waqar, Khursheed, Anjum, Alafnan, Ahmed, Batul, Rahila, Bin Break, Mohammed Khaled, Almansour, Khaled, Anwar, Sirajudheen
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 25-04-2024
• Subjects: Cancer therapy; CDK inhibitors; Cell cycle; Cyclin dependent kinase; Natural sources; CDK inhibitors; Cyclin dependent kinase; Cancer therapy; Natural sources; Cell cycle
• ISSN: 0009-2797; 1872-7786
• DOI: 10.1016/j.cbi.2024.110940

Cell division, differentiation, and controlled cell death are all regulated by phosphorylation, a key biological function. This mechanism is controlled by a variety of enzymes, with cyclin-dependent kinases (CDKs) being particularly important in phosphorylating proteins at serine and threonine sites. CDKs, which contain 20 unique components, serve an important role in regulating vital physiological functions such as cell cycle progression and gene transcription. Methodologically, an extensive literature search was performed using reputable databases such as PubMed, Google Scholar, Scopus, and Web of Science. Keywords encompassed "cyclin kinase," "cyclin dependent kinase inhibitors," "CDK inhibitors," "natural products," and "cancer therapy." The inclusion criteria, focused on relevance, publication date, and language, ensured a thorough representation of the most recent research in the field, encompassing articles published from January 2015 to September 2023. Categorization of CDKs into those regulating transcription and those orchestrating cell cycle phases provides a comprehensive understanding of their diverse functions. Ongoing clinical trials featuring CDK inhibitors, notably CDK7 and CDK4/6 inhibitors, illuminate their promising potential in various cancer treatments. This review undertakes a thorough investigation of CDK inhibitors derived from natural (marine, terrestrial, and peptide) sources. The aim of this study is to provide a comprehensive comprehension of the chemical classifications, origins, target CDKs, associated cancer types, and therapeutic applications.
[Display omitted]